Vildagliptin in the treatment of type 2 diabetes mellitus

Author： Stamataros George   Schneider Stephen H  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.12, 2011-08, pp. : 1967-1973

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update: vildagliptin for the treatment of Type 2 diabetes

By Garber Alan J   Sharma Morali D  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 1, 2008-01 ,pp. : 105-113

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin, a DPP-4 inhibitor for the twice-daily treatment of type 2 diabetes mellitus with or without metformin

By Forst Thomas   Bramlage Peter  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 9, 2014-06 ,pp. : 1299-1313

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin: A Review of its Use in Type 2 Diabetes Mellitus

By Keating Gillian M.  

Drugs, Vol. 70, Iss. 16, 2010-11 ,pp. : 2089-2112

Adis International

Access to resources Recommend Favorite

Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus

By Guarino Elisa   Nigi Laura   Patti Aurora   Fondelli Cecilia   Dotta Francesco  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 9, 2012-06 ,pp. : 1377-1384

Informa Healthcare

Access to resources Recommend Favorite

Vildagliptin: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Croxtall Jamie D.   Keam Susan J.  

Drugs, Vol. 68, Iss. 16, 2008-01 ,pp. : 2387-2409

Adis International

Access to resources Recommend Favorite